Article Details
Retrieved on: 2019-07-15 13:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. grew its position in shares of Odonate Therapeutics by 18.5% during the third quarter. <b>Vanguard Group</b> Inc. now owns 316,733 ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here